Home
Search results “Cryptogenic ischemic stroke definition”
Cryptogenic Stroke Collaborative Care Testimonial
 
04:11
In about 1 in 3 ischemic strokes, the root cause is still unknown after testing. That’s when it’s important to dig deeper for a definitive diagnosis. Collaboration by neurologists, cardiologists, electrophysiologists and other integral team members may reveal the answers needed to provide targeted treatment for preventing recurrent strokes. Look for a variety of cryptogenic stroke resources at http://spr.ly/605482W62.
Cryptogenic Strokes
 
03:45
Dr. Mary Ann Bauman tells us more about cryptogenic strokes and the new patient guide.
Views: 628 KMTV 3 News Now
Cryptogenic Stroke Patients
 
04:02
About one in four strokes in the U.S. are “cryptogenic” meaning the cause is undetermined. Statistics show cryptogenic stroke patients have reason to be concerned: A prior stroke is the number one risk factor for a second stroke. According to a new survey by the American Heart Association/American Stroke Association more than 50 percent of stroke patients and family caregivers report feeling anxious and frustrated when the cause of stroke is not detected.
Views: 80 KGUN9
Stroke syndromes OCSP  Etiology TOAST
 
06:13
This is a Learning in 10 voice annotated presentation (VAP) on Stroke syndromes OCSP Etiology TOAST To learn more about Learning in 10 (LIT), please visit learningin10.com. -- Learning in 10 (LIT) Reviews is a collection of 10-minute, user-friendly video lectures covering topics in the United States Medical Licensing Exam (USMLE) Step 2CK examination. LIT Reviews can be used by medical students to supplement their lecture materials. LIT Reviews have been created by world-class clinical faculty and each video undergoes a peer-review process to ensure accuracy of information.
Views: 427 Learning in 10
Coagulation and ischemic stroke - W Doehner
 
20:56
This video was recorded during the ESC Heart & Brain workshop course held at Charles University in Prague, Czech Republic. The goal of this first edition of this workshop was to bring together leading experts in the field of stroke and cardiologists, neurologists, radiologists, surgeons and other specialists to learn from each other. Find out more about the ESC Council on Stroke: https://www.escardio.org/Councils/Council-on-Stroke?hit=youtube
Secondary prevention after ESUS - M Rubiera del Fueyo
 
11:33
This video was recorded during the ESC Heart & Brain workshop course held at Charles University in Prague, Czech Republic. The goal of this first edition of this workshop was to bring together leading experts in the field of stroke and cardiologists, neurologists, radiologists, surgeons and other specialists to learn from each other. Find out more about the ESC Council on Stroke: https://www.escardio.org/Councils/Council-on-Stroke?hit=youtube
Stroke Survivor Story: Overcoming the Unknown
 
03:39
Dan Merritt had a stroke while waiting for a doctor’s appointment on Halloween and then a second later that night. After a third cryptogenic stroke, finding answers became the trick. Learn more about cryptogenic stroke at www.StrokeAssociation.org/CS
Cryptogenic Stroke Multidisciplinary Pathways Video
 
01:30
Learn about a collaborative care approach and model to better support stroke survivors who suffer a stroke of an unknown/unexplained cause; also known as cryptogenic stroke.
Investigating Cryptogenic Stroke
 
01:48
In many ways, cryptogenic strokes are a mystery; one that strikes a younger than normal patient population with very little warning. “Typically we see the cryptogenic stoke, which means stroke from unknown cause, in the young age group. This is the 40-60 year old population. Sometimes it’s as low as 30’s,” says Dr. Robert Cross, who is an interventional cardiologist with Lee Memorial Health System. Mostly seen in people under 45 without common risk factors, cryptogenic strokes leave little doubt, but many questions. “A patient may come in with full blown stroke symptoms - numbness, slurred speech, drooling. They’re treated aggressively then you’re looking for the reason they had the stroke,” says Dr. Cross. Cardiologists often get involved because of a potential link between cryptogenic strokes and the heart condition Afib. An irregular heartbeat heightens stroke risk and with a third of stroke survivors vulnerable to a second stroke, it is important to get answers. An implantable loop recorder is frequently used to track heart activity. “It’s a wireless system that monitors the patients to see if they have any of these arrhythmias which sometimes could take months to manifest themselves,” says Dr. Cross. Studies find monitoring long term, greatly increases the chance of identifying elusive Afib and treating it appropriately. “Is this just a benign rhythm that just needs lifestyle changes, treatment with medicines, or is this a more malignant rhythm that can predetermine stroke?” says Dr. Cross. Employing super-sleuth tactics are worth the effort to solve a life-threatening mystery. View More Health Matters video segments at leememorial.org/healthmatters/ Lee Memorial Health System in Fort Myers, FL is the largest network of medical care facilities in Southwest Florida and is highly respected for its expertise, innovation and quality of care. For nearly a century, we’ve been providing our community with everything from primary care treatment to highly specialized care services and robotic assisted surgeries. Visit leememorial.org
Views: 178 Lee Health
Cryptogenic Stroke - Dr. Babak Navi
 
01:15
Babak Navi, M.D., the Director of the Stroke Center at NewYork-Presbyterian/Weill Cornell Medical Center, discusses a clinical trial for patients who have had a cryptogenic stroke, a type of stroke where the cause is unknown. You can learn more about Dr. Navi at: http://nyp.org/physician/nbabak
Can a Biomarker Predict Which Ischemic Stroke Patients Benefit From Different Therapies?
 
03:43
From the 2013 AAN Annual Meeting: Can a biomarker predict which ischemic stroke patients benefit from anticoagulants or antiplatelet agents? In a video interview, Neurology Today's Editor-in-Chief Steven P. Ringel, MD, and Associate Editor Robert Holloway, MD, discuss the key clinical takeaways from the latest analysis of data from the Antiphospholipid Antibodies and Stroke Study and the Warfarin-Aspirin Recurrent Stroke Study. The full story here: http://bit.ly/1cZcek5
Views: 152 Neurology Today
Atherosclerosis and stroke - N Bornstein
 
20:46
This video was recorded during the ESC Heart & Brain workshop course held at Charles University in Prague, Czech Republic. The goal of this first edition of this workshop was to bring together leading experts in the field of stroke and cardiologists, neurologists, radiologists, surgeons and other specialists to learn from each other. Find out more about the ESC Council on Stroke: https://www.escardio.org/Councils/Council-on-Stroke?hit=youtube
2015 American Stroke Association Cryptogenic Stroke Conference
 
02:05
Highlights from the 2015 American Stroke Association Cryptogenic Stroke Conference in Washington, D.C. – Learn more about what the American Stroke Association is doing to advance the diagnosis and treatment of strokes of unknown etiology.
Webinar: Real World Success in Multi-Disciplinary Care of Cryptogenic Stroke Patients
 
38:51
The team from Cone Health in Greensboro, NC shares what they have learned on their multi-disciplinary journey to improving the pathway for Cryptogenic Stroke patients. The unique program links Neurology with Cardiology, working collaboratively to improve the diagnosis and treatment of Cryptogenic Stroke patients. Find additional Cryptogenic Stroke pathway resources at: Stroke-Pathway.com
Views: 435 MedtronicCardiac
Stroke (for patients & families)
 
05:52
Find more videos at http://osms.it/more. Study better with Osmosis Prime. Retain more of what you’re learning, gain a deeper understanding of key concepts, and feel more prepared for your courses and exams. Sign up for a free trial at http://osms.it/more. Subscribe to our Youtube channel at http://osms.it/subscribe. Get early access to our upcoming video releases, practice questions, giveaways and more when you follow us on social: Facebook: http://osms.it/facebook Twitter: http://osms.it/twitter Instagram: http://osms.it/instagram Thank you to our Patreon supporters: Sumant Nanduri Omar Berrios Alex Wright Suzanne Peek Arfan Azam Mingli Féng Osmosis Vision: Empowering the world’s caregivers with the best learning experience possible.
Views: 56062 Osmosis
Ischemic stroke | Wikipedia audio article
 
01:06:54
This is an audio version of the Wikipedia Article: https://en.wikipedia.org/wiki/Stroke 00:03:13 1 Classification 00:03:54 1.1 Definition 00:04:59 1.2 Ischemic 00:06:58 1.3 Hemorrhagic 00:08:32 2 Signs and symptoms 00:09:15 2.1 Early recognition 00:10:56 2.2 Subtypes 00:13:39 2.3 Associated symptoms 00:14:07 3 Causes 00:14:16 3.1 Thrombotic stroke 00:16:09 3.2 Embolic stroke 00:18:24 3.3 Cerebral hypoperfusion 00:19:25 3.4 Venous thrombosis 00:19:52 3.5 Intracerebral hemorrhage 00:20:51 3.6 Other 00:21:04 3.7 Silent stroke 00:22:14 4 Pathophysiology 00:22:23 4.1 Ischemic 00:26:34 4.2 Hemorrhagic 00:27:20 5 Diagnosis 00:28:03 5.1 Physical examination 00:28:27 5.2 Imaging 00:29:48 5.3 Underlying cause 00:31:44 5.4 Misdiagnosis 00:33:08 6 Prevention 00:34:05 6.1 Risk factors 00:35:49 6.1.1 Blood pressure 00:36:47 6.1.2 Blood lipids 00:37:16 6.1.3 Diabetes mellitus 00:37:43 6.1.4 Anticoagulation drugs 00:39:23 6.1.5 Surgery 00:41:01 6.1.6 Diet 00:41:23 6.2 Women 00:41:58 6.3 Previous stroke or TIA 00:43:15 7 Management 00:43:24 7.1 Ischemic stroke 00:44:27 7.1.1 Thrombolysis 00:46:35 7.1.2 Surgery 00:47:49 7.2 Hemorrhagic stroke 00:48:50 7.3 Stroke unit 00:49:22 7.4 Rehabilitation 00:55:56 7.5 Self-management 00:56:47 8 Prognosis 01:00:44 9 Epidemiology 01:03:09 10 History 01:05:12 11 Research 01:05:21 11.1 Angioplasty and stenting 01:05:39 11.2 Neuroprotection Listening is a more natural way of learning, when compared to reading. Written language only began at around 3200 BC, but spoken language has existed long ago. Learning by listening is a great way to: - increases imagination and understanding - improves your listening skills - improves your own spoken accent - learn while on the move - reduce eye strain Now learn the vast amount of general knowledge available on Wikipedia through audio (audio article). You could even learn subconsciously by playing the audio while you are sleeping! If you are planning to listen a lot, you could try using a bone conduction headphone, or a standard speaker instead of an earphone. Listen on Google Assistant through Extra Audio: https://assistant.google.com/services/invoke/uid/0000001a130b3f91 Other Wikipedia audio articles at: https://www.youtube.com/results?search_query=wikipedia+tts Upload your own Wikipedia articles through: https://github.com/nodef/wikipedia-tts Speaking Rate: 0.9273800195716434 Voice name: en-AU-Wavenet-C "I cannot teach anybody anything, I can only make them think." - Socrates SUMMARY ======= A stroke is a medical condition in which poor blood flow to the brain results in cell death. There are two main types of stroke: ischemic, due to lack of blood flow, and hemorrhagic, due to bleeding. They result in part of the brain not functioning properly. Signs and symptoms of a stroke may include an inability to move or feel on one side of the body, problems understanding or speaking, dizziness, or loss of vision to one side. Signs and symptoms often appear soon after the stroke has occurred. If symptoms last less than one or two hours it is known as a transient ischemic attack (TIA) or mini-stroke. A hemorrhagic stroke may also be associated with a severe headache. The symptoms of a stroke can be permanent. Long-term complications may include pneumonia or loss of bladder control.The main risk factor for stroke is high blood pressure. Other risk factors include tobacco smoking, obesity, high blood cholesterol, diabetes mellitus, a previous TIA, and atrial fibrillation. An ischemic stroke is typically caused by blockage of a blood vessel, though there are also less common causes. A hemorrhagic stroke is caused by either bleeding directly into the brain or into the space between the brain's membranes. Bleeding may occur due to a ruptured brain aneurysm. Diagnosis is typically based on a physical exam and supported by medical imaging such as a CT scan or MRI scan. A CT scan can rule out bleeding, but may not necessarily rule out ischemia, which early on typically does not show up on a CT scan. Other tests such as an electrocardiogram (ECG) and blood tests are done to determine risk factors and rule out other possible causes. Low blood sugar may cause similar symptoms.Prevention includes decreasing risk factors, as well as possibly aspirin, statins, surgery to open up the arteries to the brain in those with problematic narrowing, and warfarin in those with atrial fibrillation. A stroke or TIA often requires emergency care. An ischemic stroke, if detected within three to four and half hours, may be treatable with a medication that can break down the clot. Aspirin should be used. Some hemorrhagic strokes benefit from surgery. Treatment to try to recover lost function is called stroke rehabilitation and ideally takes place in a stroke unit; however, these are not available in much of the world.In 2013 approximately 6.9 million people had an ischemic stroke and 3.4 million people had a hemorrhagic stroke. In 2015 th ...
Views: 64 wikipedia tts
Etiology of stroke (From Medical School in Songs)
 
03:35
Take this magic carpet ride into the world of stroke and learn classification of stroke in a flash.
Views: 447 yourmusicmylyrics
What Is A Cryptogenic Stroke?
 
03:23
In this video, I describe what a cryptogenic stroke and its connection with atrial fibrillation is. A crypotegenic stroke is basically an explained stroke, and can be linked to undiagnosed atrial fibrillation. Visit my website at https://drafib.com Information is strictly educational in nature Check Out these Affiliate Links: Check out the KardiaMobile and KardiaBand - Mobile ECG for at home monitoring of atrial fibrillation- https://shareasale.com/r.cfm?b=877806&u=1919372&m=66320&urllink=&afftrack= #afib #atrialfibrillation #stroke #afibsymptoms #drafib #afibtreatment #cardiology #heart #health #doctor #hearthealth #cryoptogenicstroke
Views: 246 Doctor AFib
Cryptogenic Stroke - Sydney's Story
 
05:29
Cryptogenic Stroke - This is a common diagnosis in children and young adults with stroke.  It simply means that the cause for stroke is unknown.  While in some cases, even after thorough investigation, the cause may remain unknown, stroke experts at referral centers may offer investigations that find a cause that was missed.  Sometimes this is very important for management strategies to prevent recurrent stroke.  In children, a cause of stroke can be identified in most cases.  Our Foundation wants to provide education to local hospitals to improve diagnosis, treatment and rehabilitation of young stroke patients.   Let's work together to create solutions for families not problems.  A ray of hope is a powerful treatment for the despair that comes with a new diagnosis of stroke.
Ischemic Stroke and Transient Ischemic Attack for USMLE Step 1 and Step 2
 
01:04:14
Today we are looking at ischemic stroke and transient ischemic attack for USMLE Step 1 and Step 2. PATHOGENESIS Emboli is a major cause, which may be cardiogenic or Cardiogenic emboli leads to atrial fibrillation or atrial flutter. Mural thrombus occurs after an Myocardial infarction which forms an emboli in the left ventricular. Stroke may also be due to Valvular causes either prosthetic valve, rheumatic valve, vegetations. If there is a patent foramen ovale a stroke may also occur from a DVT. Artery to artery emboli can be from plaques located in Aorta and Carotid Artery and are audible on auscultation as a bruit. Thrombus may also be a cause of stroke that forms in carotid and vertebral artery. They decrease blood flow to the brain. Thrombus in the intracranial arteries, such as circle of willis, may also lead to eventual ischemic stroke. Lacunar infarcts occur in smaller vessels secondary to hypertension. With chronic hypertension develops lipohyalonis and fibrinoid deposition which eventually occludes the artery. TIA lasts less than 24 hours, but now defined more as whether or not infarction has occurred. TIA also increases the risk of future stroke and is associated with syncope, amnesia and seizures. Must differentiate multiple sclerosis, brain tumor, brain abscess and intracerebral hemorrhage. RISK FACTORS Risk factors for stroke are generally the same as MI, Hypertension, Atherosclerosis, Diabetes and obesity. Also hypercoagulable state, amyloid angiopathy. Atrial Fibrillation, MI, Previous TB. NEUROANATOMY Anterior Circulation – Begins with internal carotid artery. Then branches anteriorly to Anterior Cerebral Artery and the Middle Cerebral Artery. Posterior Circulation – Starts with the vertebral artery and gives off branches to the Posterior Inferior Cerebellar Artery (PICA). Combines to form the Basilar Artery, Superior Cerebellar Artery and the Posterior Cerebral Artery (PCA). STROKE SYNDROMES Stroke in Internal Carotid Artery is usually due to atherosclerotic plaque, but are generally asymptomatic because of compensation from circle of Willis. However, patient may still experience monocular blindness and a bruit. Strokes in the anterior cerebral artery (ACA) affect the lower extremity, abulia and urinary incontinence. Strokes in the middle cerebral artery (MCA) affect the upper limb and face as well as speech, decrease conjugate gaze, homonymous hemianopia. Lacunar strokes present with pure motor or pure sensory loss, ataxia, clumsy hand. Vertebral artery strokes are divided as extracranial which is known as the subclavian steal syndrome, and intracranial strokes affect the medullar oblongata. Anterior Spinal Artery Strokes Lateral Medullar Syndrome aka Wallenberg Syndrome, PICA syndrome have ipsilateral pain and numbness in the face, diplopia, vertigo, nausea/vomiting and Horner Syndrome. On the contralateral defect in pain and temperature in the body. Medial Medullar Syndrome is due to stroke in the anterior cerebellar artery. Ipsilateral tongue paralysis due to 12 cranial nerve. Contralateral paralsysi and decrease proprioception due to pyramidal and medial lemniscus. Basilar artery strokes leads to locked in syndrome and there is no volitional besides moving their eyes. Strokes affecting the midbrain include CN 3 and so they will have down and out. If there is contralateral hemiplegia is known as weber syndrome. Benedikt Syndrome there is additional gait abnormalities. Posterior Cerebral Artery strokes have visual problems and homonymous hemianopia with macular sparing. MANAGEMENT Start with the airway, breathing, circulation. Then check blood glucose and ABG that might mimic strokes. Non-contrast CT within 25 minutes to rule our hemorrhage, which will require surgery. Then begin thrombolysis or thrombolectomy. Contraindications for thrombolysis include, history of stroke or head trauma, atriovenous malformation, aneurysm, recent surgery, hypertension, hypoglycemia, internal bleeding, coagulopathy. Must be given less than 3 hours. Thrombolectomy only up to internal carotid artery. Then determine the cause with Doppler ultrasound of carotid or vertebral artery. CT Angiography or MRA looking for thrombus of smaller arteries and distinguish where the lesion or stroke occurred. Transcranial Doppler helps identify in MCA, ACA, PCA strokes. Cardiac evaluation to look for emboli in the heart with echo, ECG, lipid levels.
Views: 16510 the study spot
#10 Cryptogenic stroke: Solving the unsolved
 
16:45
Diagnostic dilemmas, cryptogenic infarcts account for almost a third of all stroke subtypes. But if you break it down, it's really not so complicated. In our tenth episode, Dr. Noah Levinson gets some insight into the diagnostic approach of this confounding condition. BrainWaves podcasts and online content are intended for medical education only and should not be used to guide medical decision making in routine clinical practice. Any cases discussed in this episode are fictional and do not contain any patient health identifying information. The content in this episode was vetted and approved by Michael Mullen. REFERENCES 1. Hart RG, Diener HC, Coutts SB, Easton JD, Granger CB, O'Donnell MJ, Sacco RL, Connolly SJ and Cryptogenic Stroke EIWG. Embolic strokes of undetermined source: the case for a new clinical construct. The Lancet Neurology. 2014;13:429-38. 2. Jacobs BS, Boden-Albala B, Lin IF and Sacco RL. Stroke in the young in the northern Manhattan stroke study. Stroke; a journal of cerebral circulation. 2002;33:2789-93. 3. Putaala J, Metso AJ, Metso TM, Konkola N, Kraemer Y, Haapaniemi E, Kaste M and Tatlisumak T. Analysis of 1008 consecutive patients aged 15 to 49 with first-ever ischemic stroke: the Helsinki young stroke registry. Stroke; a journal of cerebral circulation. 2009;40:1195-203. 4. Bang OY, Lee PH, Joo SY, Lee JS, Joo IS and Huh K. Frequency and mechanisms of stroke recurrence after cryptogenic stroke. Annals of neurology. 2003;54:227-34.
Views: 18 BrainWaves Staff
Dr Subhash Kaul - PFO Closure in ESUS Stroke? (Yes)
 
21:57
Should closure of PFO be recommended treatment and standard care of patient with ESUS ? PFO is associated with cryptogenic stroke (stroke of unclear etiology). PFO is present in 20-25% of the adult population, but in 40% of adults with cryptogenic stroke.  Despite the association between PFO and cryptogenic stroke, three early randomized clinical trials (CLOSURE I, PC trial, and RESPECT short-term) did not show a clear benefit of PFO closure for secondary stroke prevention. In March 2016, a meta-analysis of patient-level data from CLOSURE I, PC, and RESPECT was published. This meta-analysis found that PFO closure was superior to medical therapy for the prevention of recurrent ischemic stroke. When the analysis was restricted to the trials in which only the Amplatzer PFO occluder device was used (PC and RESPECT), the benefit appeared even greater. Should closure of PFO be recommended treatment and standard care of patient with ESUS ? Dr. Subhash Kaul MD (Gen Medicine), DM (Neurology), FRCP(Glasgow), FAAN (USA)Sr. Consultant Neurologist Qualifications: MBBS, Govt. Medical College, Srinagar, 1975-80MD (Gen.Medicine), Govt.Medical College, Srinagar, 1980-85DM (Neurology), PGIMER, Chandigarh, 1985-90Stroke Fellowship (NIH Maryland, USA), 1994-1996 Experience : Professor of Neurology, Head Unit II, NIMS, Hyderabad 2000-04 Head, Department of Neurology, NIMS, Hyderabad 2004-18 Dean Incharge, NIMS, Hyderabad 2015-18 Publications: 120 in National and International journals Awards And Honors: State Teachers Award, Government of Telengana 2017Past President, Andhra Pradesh Neuroscientists AssociationPast President, Indian Stroke AssociationPast President, Indian Academy of NeurologyFellow of Indian Academy of NeurologyFellow of American Academy of NeurologyFellow of American Stroke AssociationFellow of Royal College of Physicians (Glasgow)
Views: 179 Stroke Neurology
Prof M V Padma (AIIMS) - PFO Closure in ESUS ? (No)
 
19:40
Should closure of PFO be recommended treatment and standard care of patient with ESUS ? PFO is associated with cryptogenic stroke (stroke of unclear etiology). PFO is present in 20-25% of the adult population, but in 40% of adults with cryptogenic stroke. Despite the association between PFO and cryptogenic stroke, three early randomized clinical trials (CLOSURE I, PC trial, and RESPECT short-term) did not show a clear benefit of PFO closure for secondary stroke prevention. In March 2016, a meta-analysis of patient-level data from CLOSURE I, PC, and RESPECT was published. This meta-analysis found that PFO closure was superior to medical therapy for the prevention of recurrent ischemic stroke. When the analysis was restricted to the trials in which only the Amplatzer PFO occluder device was used (PC and RESPECT), the benefit appeared even greater. Should closure of PFO be recommended treatment and standard care of patient with ESUS ? Prof. M V Padma Srivastava(MBBS, MD, DM. FAMS, F.N.A.Sc) Dr Padma Srivastava has a primary area of interest in Stroke, Vascular Dementia and Multiple Sclerosis besides actively participating in the Epilepsy Program at AIIMS. She initiated the Hyperacute Reperfusion strategies including the thrombolysis program  for acute ischemic stroke at AIIMS. She is currently the President of the Indian Stroke Association and was instrumental in formulating the India Stroke Guidelines which are now endorsed by the ISA. She has been the visiting professor to the Department of Neurology, UMASS, Boston. She has more than 200 publications in peer reviewed publications including journals and chapters in books. She is also the recipient of the prestigious Vimla Virmani Oration,  Achanta Laxmipathy Oration from  NAMS, K.L.Wig Oratin from API & Fellowship from NAMS and NASI.
Views: 128 Stroke Neurology
New Updates in Ischemic Stroke and TIA
 
40:31
This is a Grand Rounds from the Department of Emergency Medicine at the University of Ottawa. The presenter is Dr. Simeon Mitchell. The presenter has no conflicts of interest to declare. The views and opinions expressed on this video are those of Dr. Mitchell's and do not necessarily reflect the views and opinions of The Department of Emergency Medicine at the University of Ottawa or The Ottawa Hospital. This video should not be construed as personal medical advice and is not intended to replace medical advice offered by physicians.
Views: 3858 EM Ottawa
PFO Stroke Animation
 
00:46
Dr. Robert J. Cubeddu is the Medical Director of the Structural and Adult Congenital Heart Program at Aventura Hospital and Medical Center, Miami, Florida. Dr. Cubeddu trained at the Massachusetts General Hospital in Harvard Medical School where he acquired expertise training in minimally invasive catheter-based technology to treat multiple structural heart related conditions. In this interview we had the honor to meet Dr. Cubeddu and speak with him about PFO closure. Q: What is a PFO? A: A PFO is the abbreviated term for "patent foramen ovale"; a small "tunnel-like" hole or communication present along the septal wall that separates the upper two chambers of the heart. Typically this hole closes shortly after birth, however in some people the hole may never close and can remain open throughout adulthood. Q: How many people have a PFO? A: It is estimated that approximately 20% of adults have a PFO, that is 1 in 5 people. In most cases, having a PFO is medically not important. However, in a small percentage of patients with a PFO it may be associated with the development of stroke and/or migraine headaches. Q: How do you check for PFO? A: A PFO can be diagnosed with a conventional echocardiogram using the administration of "agitated saline" . This diagnostic test is simple, routine, non-invasive, and takes approximately 10-15 minutes. Q: Who should be checked for a PFO? A: Patients with unexplained strokes or history of debilitating migraine headaches should be evaluated for a PFO. Q: Can patients have their PFO closed? A: Yes, PFO closure is possible and recommended in some patients. The objective of closing the PFO is to prevent future strokes in patients who have not had success with blood thinners or simply cannot take them. Q: How can patients have their PFO closed? A: Nowadays, PFO closure may be performed by skilled operators with expertise training in structural heart interventions. The procedure takes approximately 1-2 hours and is performed through a minimally invasive 5 mm incision at the level of the groin under local anesthesia. A long catheter is carefully maneuvered up to the heart across the PFO. A special double-umbrella device is then delivered through this catheter to close the PFO successfully. The procedure is pain-free. Recovery times are short with nearly all patients discharged by the following morning. Q: Are migraine sufferers considered candidates for closure? A: Currently the evidence to support PFO closure in patients with migraines is relatively controversial. However in some patients with disabling migraines and who are unresponsive to medical therapy, PFO closure may be considered. Q: Tell us about recent cases you've conducted? A: We have had many stroke victims referred for PFO closure. I am happy to say that our experience has been 100% success. For more information about PFO closure, and other innovative catheter-based structural heart disease interventions including: • Percutaneous valve replacement. • Repair of congenital heart defects. • Alcohol septal ablation. • And other stroke prevention strategies in patients with atrial fibrillation contact Dr. Cubeddu at 786-428-1059 or visit us at http://aventura.floridaheartandvascular.com , serving Aventura and surrounding Miami-Dade and Broward county. ================================================
Views: 40007 AHMCaventura
Improving Outcomes in Stroke
 
01:48
Trials have shown that endovascular thrombectomy within 6 hours after the onset of ischemic stroke symptoms has a clinical benefit, but the effect after more than 6 hours is not known. New research findings are summarized in a short video. See the related NEJM article: http://www.nejm.org/doi/full/10.1056/NEJMoa1706442
Views: 3330 NEJMvideo
Young Stroke
 
05:44
Stroke is often considered as an older person's disease, and only 10% of stroke patients are younger than 50 years. But Recent reports show an apparent increasing trend in ischemic stroke among young adults, a figure that is particularly concerning, when compared to the overall decrease in stroke incidence and mortality. Although certain rare risk factors have been suggested as possible causes, reports show that traditional risk factors for stroke also high in this population. The lifetime impact of stroke on young adults carries substantial costs to the individual's family and to society. Youtube Channel: https://www.youtube.com/user/drzulfiquar Facebook: https://www.facebook.com/drzulfiquarahmed Google+: https://plus.google.com/+ZulfiquarAhmed Website: http://www.drzulfiquar.com
Views: 140 Dr. Zulfiquar Ahmed
Unusual Causes of Stroke
 
15:14
There multiple causes of stroke, many of them out of the ordinary.
Views: 551 HenryFordTV
PFO closure for cryptogenic stroke CATCD 2008
 
07:08
Saibal Kar MD, Mark Reisman MD, Greg Fontana MD, and Jonathan Tobis MD discuss PFO closure to treat cryptogenic stroke at the 2008 Controversies and Advances in the Treatment of Cardiovascular Disease in Los Angles.
Views: 2849 CardiacControversies
International Academy of Cardiology: J. Rod Gimble, M.D.: CRYPTOGENIC STROKE - COULD LONG TERM
 
02:27
CRYPTOGENIC STROKE - COULD LONG TERM CARDIAC MONITORING UNCOVER THE CAUSE J. Rod Gimbel, M.D. Knoxville, TN, USA Presented at the: International Academy of Cardiology 18th World Congress on Heart Disease Annual Scientific Sessions 2013 Vancouver, B.C., Canada July 26-29, 2013 Congress Chairman: Asher Kimchi, M.D. http://www.CardiologyOnline.com Cardiology Online To read more about this presentation click here to download the Word file: http://www.cardiologyonline.com/wchd13/Abstracts/PL10/3119%20Gimbel.doc PLAN TO ATTEND: International Academy of Cardiology Annual Scientific Sessions 2017 22nd World Congress on Heart Disease Vancouver, BC, Canada July 14-July 16, 2017 Congress Chairman: Asher Kimchi, M.D. http://www.CardiologyOnline.com
Views: 374 Cardiology Online
Recurrent Stroke with Patent Foramen Ovale: Updated Guideline - American Academy of Neurology
 
01:14
The AAN has updated its Practice Advisory for Recurrent Stroke with Patent Foramen Ovale, or a hole in the heart. Access additional tools at AAN.com/guidelines. Visit the American Academy of Neurology at https://www.aan.com Connect with the AAN Facebook: http://bit.ly/2feMxW4 Twitter: https://bit.ly/1orvPet Instagram: http://bit.ly/2eVgsz4 LinkedIn: http://bit.ly/22mKzkM
Views: 598 AANChannel
Economic Value of Reveal LINQ™ Insertable Cardiac Monitor in Cryptogenic Stroke Patients
 
03:58
This video is directed to Health Care Professionals across Europe and describes the Economic Value of the Reveal LINQ™ Insertable Cardiac Monitor (ICM). The Reveal LINQ™ is an innovative and powerful solution with proven clinical effectiveness and economic value to increase patient quality of life and reduce stroke-related costs. For more information visit us at www.medtronicdiagnostics.com
Views: 146 MedtronicEurope
CRYSTAL AF
 
10:02
Walter Kernan, MD interviews Richard Bernstein, MD, primary investigator of the study, "Cryptogenic Stroke and Underlying Atrial Fibrillation (CRYSTAL AF), which he presented at ISC 2014 in San Diego.
Views: 884 AHAScienceNews
Animation showing an ischaemic stroke
 
00:13
In an ischaemic stroke the blood vessel is blocked by a blood clot, which interrupts the brain’s blood supply. Please visit the 'Self-Help 4 Stroke' website, a self-management resource for people who have had a stroke - http://selfhelp4stroke.org
Mercy Stroke Coordinator Discusses TIAs
 
03:19
Diane Handler, Mercy Medical Center Stroke Coordinator, discusses Transient Ischemic Attacks (TIAs) with Ashley Hinson of KCRG-TV9 News on April 9, 2012. TIAs are warning signs that a major stroke could occur soon. Learn about risk factors, symptoms and what to do if you have one.
Views: 196 Mercy Cedar Rapids
PFO Predicts Stroke for Patients with Endocardial Leads
 
01:19
In Circulation, researchers report whether a PFO increases the risk of stroke or TIA in patients with endocardial leads.
Genetics of Stroke: Getting Up Close & Personal (Dr. Guillaume Paré) Heart & Stroke Clinical Update
 
39:08
Heart & Stroke Clinical Update 2017 www.clinicalupdate.ca Want to join the Heart & Stroke Clinical Update in Toronto next year? Email [email protected] with the subject line: CU to receive event information Keynote Address - Genetics of Stroke: Getting Up Close And Personal Presented by - Guillaume Paré MD, MSc, FRCPC (see below) Hilton Toronto, December 2017 Learning objectives: Upon completion of this session, participants will be equipped to: • Understand principles of evidence-based pharmacogenetics • Understand the latest developments in anti-platelet pharmacogenetics • Understand the latest developments in anti-coagulant pharmacogenetics Guillaume Paré MD, MSc, FRCPC Associate Professor, McMaster University Canada Research Chair in Genetic & Molecular Epidemiology Director, Genetic and Epidemiology Laboratory Want to join the Heart & Stroke Clinical Update in Toronto next year? Email [email protected] with the subject line: CU to receive event information The following video was provided with the permission of the speaker. The information is intended for the use of healthcare professionals for reference and education only and is not intended to be a substitute for healthcare professional advice, diagnosis or treatment. You should consult your healthcare professional for personal health matters.
Views: 198 Heart & Stroke
Stroke Care Continuum Economic Value
 
06:54
This video is directed to Health Care Professionals across Europe and describes the Economic Value of Medtronic innovative solutions through the stroke care continuum specifically of Solitaire™, Reveal LINQ™ and Synchromed™ infusion system.
Views: 555 MedtronicEurope
Vanja Douglas, MD, Acute Stroke Treatment Part 2: Small Vessel and Large Vessel Strokes
 
10:05
How do small vessel strokes differ from large vessel strokes? Dr. Douglas illustrates these differences, and discusses effects & pathology. More on Dr. Douglas: http://profiles.ucsf.edu/vanja.douglas UC San Francisco advances health through education, research, patient care and public service. With seven major sites in the San Francisco Bay Area and Fresno, the UCSF School of Medicine is dedicated to improving human health by accelerating scientific discovery and transforming medical education. The school’s new Bridges curriculum is pioneering a new approach to medical education to prepare physicians for practice in the 21st century. Through mentorship and collaborative learning, students are trained to care for patients, conduct research and contribute vital knowledge to improve our health system. Visit our channel home page: https://www.youtube.com/c/UCSFSchoolofMedicine Subscribe to this channel: https://www.youtube.com/channel/UCprcipiXNXTzJYJfN02rHsA?sub_confirmation=1
Stroke gene discovered
 
11:57
Ischemic stroke is the second leading cause of death worldwide. Only one moderately effective therapy exists, albeit with contraindications that exclude 90% of the patients. This medical need contrasts with a high failure rate of more than 1,000 pre-clinical drug candidates for stroke therapies. Thus, there is a need for translatable mechanisms of neuroprotection and more rigid thresholds of relevance in pre-clinical stroke models. One such candidate mechanism is oxidative stress. However, antioxidant approaches have failed in clinical trials, and the significant sources of oxidative stress in stroke are unknown. We here identify NADPH oxidase type 4 (NOX4) as a major source of oxidative stress and an effective therapeutic target in acute stroke. Upon ischemia, NOX4 was induced in human and mouse brain. Mice deficient in NOX4 (Nox42/2) of either sex, but not those deficient for NOX1 or NOX2, were largely protected from oxidative stress, blood-brain-barrier leakage, and neuronal apoptosis, after both transient and permanent cerebral ischemia. This effect was independent of age, as elderly mice were equally protected. Restoration of oxidative stress reversed the stroke-protective phenotype in Nox42/2 mice. Application of the only validated low-molecular-weight pharmacological NADPH oxidase inhibitor, VAS2870, several hours after ischemia was as protective as deleting NOX4. The extent of neuroprotection was exceptional, resulting in significantly improved long-term neurological functions and reduced mortality. NOX4 therefore represents a major source of oxidative stress and novel class of drug target for stroke therapy. Citation: Kleinschnitz C, Grund H, Wingler K, Armitage ME, Jones E, et al. (2010) Post-Stroke Inhibition of Induced NADPH Oxidase Type 4 Prevents Oxidative Stress and Neurodegeneration. PLoS Biol 8(9): e1000479. doi:10.1371/journal.pbio.1000479
Views: 741 Harald Schmidt
Clinical Trials - Navigate Esus
 
08:54
The Navigate Esus Trial, presented and discussed at the 4th European Stroke Organisation Conference (ESOC 2018) by Geroge Ntaios & Robert Hart. Learn more on the ESOC website: https://eso-conference.org/2019/information/esoc-2018-conference-news
Carotid Dissection Stroke - Laressa's Story
 
04:43
Our mission is to educate doctors throughout the United States but at Children's Stroke Foundation if we can teach anyone who listens, we will. We will post a series of videos every other month about the different causes we know cause Stroke in children, teens and young adults. Each one will be short but informative. This first video is "Stroke by Accident" - an awful experience for this little girl whose strokes could have been avoided. But through this accident Children's Stroke Foundation was founded! Children's Stroke Foundation exists now to help families and promote stroke education among the U.S. medical network. "The world is a university and everyone in it is a teacher. Make sure when you wake up in the morning you go to school" -Bishop T.D. Jakes.
Charité Clinical Journal Club by Fred Luft - 1.6.2016
 
51:05
The N Engl J Med image of the week shows CT scan coronal view of the abdomen with contrast material. We observe a hugely dilated bowel that I would interpret as bowel ischemia and mesenteric edema. We are given the clue of renal failure. The options are all antibodies: IgA anti-tissue transglutaminase, IgG antibodies against Lyme disease, Heliobacter pylori stool antigen, antimitochondial antibodies, and antineutrophil cytoplasmic antibodies. The first three clinical papers are an example of how to squeeze three papers out of a single clinical study. Hope-3 was a 2x2 multifactorial study of placebo, blood pressure reduction, LDL cholesterol reduction, or both together. The subjects were about 13,000 persons with “intermediate risk of cardiovascular disease (no prior events, but at least one major risk factor, namely elevated waist-to-hip ratio, history of low concentration of high-density lipoprotein cholesterol, current or recent tobacco use, dysglycemia, family history of premature coronary disease, and mild renal dysfunction). In the first study, we compare candesartan+hydrochlorothiazide, which lowered blood pressure about 6 mm Hg compared to placebo for 7 years. This blood pressure reduction did not decrease cardiovascular endpoint events, compared to placebo. In the next study, we compare rosuvestatin 10 mg to placebo. This strategy lowered LDL cholesterol by 25% and there were less events in the treatment group. The absolute reduction was 1.5%, at the expense of muscle symptoms. C-reactive protein made no difference. In the third study, both treatments together were compared to placebo. The first coprimary outcome was the composite of death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke, and the second coprimary outcome additionally included heart failure, cardiac arrest, or revascularization. The combination of rosuvastatin (10 mg per day), candesartan (16 mg per day), and hydrochlorothiazide (12.5 mg per day) was associated with a significantly lower rate of cardiovascular events than dual placebo among persons at intermediate risk who did not have cardiovascular disease. However, the number-needed-to treat is about 60. These treatments are for the “worried” well. I believe what will come eventually is a “polypill” for the worried. Hemophilia A is congenital factor VIII deficiency. It is treated with either plasma-derived or recombinant factor VIII. With both treatments receiving injections about every-other-day, antibodies can develop resulting in “resistance”. Investigators conducted a randomized trial to assess the incidence of factor VIII inhibitors among patients treated with plasma-derived factor VIII containing von Willebrand factor or recombinant factor VIII. Patients treated with plasma-derived factor VIII containing von Willebrand factor had a lower incidence of inhibitors than those treated with recombinant factor VIII. It may be that the plasma-derived factor-VIII material has its epitopes covered by von Willebrand factor, thereby minimizing inhibiting antibody formation. In patients with severe hemophilia A, standard treatment is regular prophylactic and episodic intravenous infusions of factor VIII. However, these treatments are burdensome, especially for children, and may lead to the formation of anti–factor VIII alloantibodies (factor VIII inhibitors). Emicizumab (ACE910), a humanized bispecific antibody mimicking the cofactor function of factor VIII, was developed to abate these problems. The antibody bridges factor IX and factor X, thereby bypassing factor VIII. This novel strategy was a great success. Once-weekly subcutaneous administration of emicizumab markedly decreased the bleeding rate in patients who had hemophilia A with or without factor VIII inhibitors. The N Engl J Med review is on cryptogenic stroke. Cryptogenic ischemic strokes are symptomatic cerebral infarcts for which no probable cause is identified after adequate diagnostic evaluation. This problem involves about 25% of all stroke cases. The case of the week is a 31 year-old woman pregnant with twins who develops recurrent fever and signs of bacterial infection. This patient has Listeriosis, an infection well-known in pregnant women but quite unusual today. The varicocele patient from last week indeed had a left-sided renal cell carcinoma. In the Lancet, we learn that despite successful treatment of the culprit artery lesion by primary percutaneous coronary intervention (PCI) with stent implantation, thrombotic embolisation occurs in some cases, which impairs the prognosis of patients with ST-segment elevation myocardial infarction (STEMI). Invesitgators aimed to assess the clinical outcomes of deferred stent implantation versus standard PCI in patients with STEMI.

Here!
Daily news usa video chat
Here!
Here!
Here!